Skip to main content
Sign In

Home Future StudentsCurrent StudentsFaculty & StaffPatientsAlumni

University of Colorado College of Nursing

College of Nursing
 

Faculty Profile

Mary Weber, PhD, APRN, PMHNP-BC

Associate Professor

Mary.Weber@ucdenver.edu

Dr. Weber has re-developed and re-opened a Master's-level Psychiatric Mental Health Nurse Practitioner option at the CU Denver College of Nursing. Dr. Weber has twenty years of clinical experience in various roles--approximately 15 of those years were spent in psychiatric nursing as a CNS/NP. She has over 10 years teaching nursing at the graduate level. Her research focuses on the impact of treatment on the health and co-morbidities of those who are homeless and also have mental illness or substance-use disorders.

Degree Awarding Institution Field of Study Graduation Date
BSN University of Miami
Coral Gables, Florida		 Nursing 1980
MSN/ARNP University of Miami
Coral Gables, Florida		 Geriatric /Gerontological 1984
Post-MSN, PMHNP University of Florida
College of Nursing
Gainesville, Florida 		Adult Psych NP/CNS 1991
PhD University of Florida
College of Nursing
Gainesville, Florida 		Nursing 1997
  1. Weber, M, Gutierrez, A., Mohammadi, M The Risks and Benefits of Switching antipsychotics: A case study approach Accepted for Publication, Perspectives in Psychiatric Care.
  2. Weber, M., Colon, M., Nelson, M (2008). Pilot study of a cognitive behavioral group intervention to prevent further weight gain in Hispanic individuals with schizophrenia, Journal of the American Psychiatric Nurses Association, 13, 353-359. *
  3. Weber, M & Snow, D. (2006). An introductory clinical core course in Psychiatric Management: An innovative lifespan course blending all nurse practitioner majors, Perspectives in Psychiatric Care, 42, 245-251.
  4. Weber, Mary & Wyne, K., (2006) A cognitive/behavioral group intervention for weight loss in patients treated with atypical antipsychotics. Schizophrenia Research, 83, 95-101. *
  5. Henderson, David, Cagliero, Copeland, Borba, Evins, Hayden, Weber, M.T., et al. (2005).   Glucose metabolism in schizophrenia patients treated with atypical antipsychotics: A frequent sampled Intravenous Glucose Tolerance Test and Minimal Model AnalysisArchives of General Psychiatry, 62, 19-28. *
  6. Byerly, J., Lescouflair, E., Weber, M., Bugno, R, Fisher, R., Carmody, T, Varghese, F., Rush, A. (2004) An Open-Label Trial of Quetiapine for Antipsychotic-Induced Sexual Dysfunction. Journal of Sex and Marital Therapy, 30, 325-332. *
  7. Byerly, M., Weber, M., Brooks, D., Casey, S., Elliot, S. & Hawkins, J (2003). Cost Evaluation of Risperidone versus Olanzapine: A Database and chart review Psychiatric Services, 54, 742-744 *
  8. Allison, D. & Weber, M. (2003) Treatment and prevention of obesity: What works, what doesn't work, and what might work Invited article in Lipids, 38, 147-155.
  9. Weber, M.T. (2002) Triggers for Self-Abuse: A qualitative study Archives of Psychiatric Nursing, 16, 118-124.*
  10. Byerly, M.J., Weber, M.T., Snow, L., Worley, M. & Slater, A. (2001) Cognitive effects of antipsychotics in the elderly, Drugs and Aging, 18, 45-61.
  11. Hudson, A., Jones, L. & Weber, M.T. (1999) Adult survivors of childhood sexual abuse as patients: Two case studies Journal of Wound, Ostomy, and Continence Nursing, 26, 60-65.
  12. Tappen, R. & Weber, M. T. (1992) Treating clients and families together in an Alzheimer day care center, American Journal of Alzheimer's Care and Research, 7, 24-30. *
  13. Brower, H., Tappen, R., Weber, M. T. (1988) Missing links in nurse practitioner education, Nursing and Health Care, 9, 33-36.
  • 2007/2008 Principal Investigator, Genomic predictors of Diabetes and obesity in high-risk populations with schizophrenia.
  • 2006/2007 Principal Investigator, Diabetes and Cardiovascular Risk Assessment in African American females with Schizophrenia.
  • 2005/2006 Co-Principal Investigator, University of Texas at Arlington, with David Henderson, MD, Harvard University, "An open label trial of ziprasidone as an adjunct to clozapine or olanzapine associated diabetes mellitus, impaired fasting glucose, or insulin resistance in chronic schizophrenia" $10,000 to DallasMetrocare for startup funds.
  • 2003 Principal Investigator, University of Texas at Arlington School of Nursing Faculty Scholarship, $5000.00 for salary support for summer, 2003 Pilot study on Cognitive/Behavioral group intervention for Hispanic subjects with schizophrenia.
  • 2003 Principal Investigator, University of Texas at Arlington Research Enhancement Grant, $10,000 for Research Assistant and patient costs, September 1, 2003- September 1, 2004 "The effects of a 12 week Cognitive/Behavioral intervention on hyperglycemia and weight gain among individuals with schizophrenia taking atypical antipsychotics"
  • 2002 Investigator, Pilot study on Cognitive/Behavioral Group for the treatment of antipsychotic-induced weight gain. No funding source.
  • 2001 Awarded NIMH/NINR Mentorship program: Building Capacity of Psychiatric Mental Health Researchers, $1500, mentor Dr. David Allison from University of Alabama at Birmingham, submitted "mock" RO1 for committee review and feedback (2003)